Loading
CC
Crescent Capital BDC, Inc. Stock: price and insider trades · United States
2 insiders bought €42k of shares over the last 90 days, the latest by Chung Henry, filed 21 Aug 2026.
Crescent Capital BDC, Inc.: what insiders have been doing
Crescent Capital BDC, Inc., classified in the Finance & Banking sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). From 18 October 2025 to 18 October 2026, the disclosure feed for Crescent Capital BDC, Inc. logged 18 filings by 5 insiders.
Open-market activity splits into 5 purchases totalling €158k and 12 sales totalling €4.7M; 3 insiders sit on the buying side and 1 insider on the selling side. Sales outweigh purchases by €4.6M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The largest single trade was a sale of €1.2M by Fidelity & Guaranty Life Insurance Co, published on 9 September 2026. On the buying side, the filings list 2 chief executives and 1 finance chief among the declarants.
In all, 2 purchases were made within 30 days of a purchase by another insider of the company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The clock since the last published purchase (21 August 2026) now reads 58 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Compared with its exchange (5,458 companies, median 22 filings), a count of 18 filings is below the norm. Over the whole record (from 2021), the tally stands at 27 purchases and 20 sales.
Other companies in the same sector with recent insider buying flagged by our signals: First Guaranty Bancshares, Inc. and BCB Bancorp Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
53
Thresholds
n/a
Buy Volume
€1M
27 ops. · all time
Sell Volume
€8M
20 ops. · all time
Who traded when
BuySaleFidelity & Guaranty Life Insurance Co12 sales
Gerhard Lombard2 buys
Henry Chung2 buys
Raymond Barrios2 buys
Jason Breaux1 buy
Kirill Bouek1 buy
+1 other insider
Since the insiders bought
- +0.4%Entry US$25.07 · Close at T+90 US$25.16
- -3.2%Entry US$24.48 · Close at T+365 US$23.70
- -3.2%Entry US$24.48 · Close at T+365 US$23.70
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 1,663 of 23,476 companies
76.7
score / 100
Value91
Quality63
FCF yld23%
Earn yld11%
EV/EBITDA·
ROE-0.5%
Gross mgn·
Net mgn73%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$8.90
Analyst consensus
7 analystsUS$10.25Target US$12.25(+38%)US$14.00
Income statement
RevenueUS$47.4M
Net incomeUS$34.5M-2.0% margin
Valuation
PER (forward)6.4x
P/Book0.5x
Beta0.62
Balance sheet & cash
Market capUS$327.9M
Total debtUS$873.8M
Free Cash FlowUS$74.7M
Debt / Equity141%
Profitability & ownership
ROE-0.5%
ROA4.6%
% insiders3.4%
% institutions71.8%
Last declaration on 9 September 2026
Declarations53 total
126,436 shares@ US$10.332212.4% of flowCommon StockSEC:0000854241-26-000007:0
139,054 shares@ US$10.228813.5% of flowCommon StockSEC:0000854241-26-000007:1
5,011 shares@ US$10.33950.5% of flowCommon StockSEC:0000854241-26-000006:0
10,471 shares@ US$10.38631.0% of flowCommon StockSEC:0000854241-26-000006:1
525,000 shares@ US$9.7548.2% of flowCrescent Capital BDC IncSEC144:0002085541-26-000005
45,000 shares@ US$10.44484.5% of flowCommon StockSEC:0000854241-26-000005:1
11,285 shares@ US$10.501.1% of flowCommon StockSEC:0000854241-26-000005:0
15,000 shares@ US$10.6021.5% of flowCommon StockSEC:0000854241-26-000004:0
40,000 shares@ US$10.62054.0% of flowCommon StockSEC:0000854241-26-000004:1
32,091 shares@ US$10.60133.2% of flowCommon StockSEC:0000854241-26-000003:0
27,195 shares@ US$10.60432.7% of flowCommon StockSEC:0000854241-26-000003:1
33,457 shares@ US$10.71693.4% of flowCommon StockSEC:0000854241-26-000002:0
40,000 shares@ US$10.73984.0% of flowCommon StockSEC:0000854241-26-000002:1
2,500 shares@ US$10.8934.7% of flowCommon StockSEC:0001193125-26-361209:0
Canonical exit: 17 Nov 2026 (T+90)
2,000 shares@ US$10.9120.0% of flowCommon StockSEC:0001193125-26-359278:0
Canonical exit: 17 Nov 2026 (T+90)
4,500 shares@ US$11.4565.3% of flowCommon StockSEC:0001193125-26-236953:0
Canonical exit: 19 Aug 2026 (T+90)
5,000 shares@ US$11.1927.7% of flowCommon StockSEC:0001193125-26-234592:0
Canonical exit: 18 Aug 2026 (T+90)
2,000 shares@ US$13.341524.4% of flowCommon StockSEC:0001193125-25-286161:0
Canonical exit: 15 Feb 2026 (T+90)
200 shares@ US$15.666622.1% of flowCommon StockSEC:0000950170-25-112230:0
Canonical exit: 26 Nov 2025 (T+90)
2,230 shares@ US$15.631622.3% of flowCommon StockSEC:0000950170-25-111489:0
Canonical exit: 23 Nov 2025 (T+90)
1,015 shares@ US$15.6210.1% of flowCommon StockSEC:0000950170-25-111489:1
Canonical exit: 23 Nov 2025 (T+90)
22,910 shares@ US$15.55100.0% of flowCommon StockSEC:0001140361-25-031789:0
1,511 sharesCommon StockSEC:0001209191-23-057436:0
6,044 sharesCommn StockSEC:0001209191-23-057420:0
3,022 sharesCommon StockSEC:0001209191-23-057391:0
25 of 53 declarations
About Crescent Capital BDC, Inc.
Crescent Capital BDC, Inc. is a U.S.-listed business development company focused on middle-market corporate credit. The company is designed to generate current income, with capital appreciation as a secondary objective, by investing primarily in senior secured and other forms of private credit, and selectively in hybrid or equity-linked instruments when the risk-reward profile is attractive. For French-speaking investors looking at a listed credit vehicle, Crescent BDC offers exposure to private lending in the United States, a segment that is typically less directly tied to broad equity-market cycles than traditional cyclical industries.
The company sits within the Crescent Capital Group platform, a long-established alternative credit manager founded in 1991 and known for its corporate credit expertise across direct lending, mezzanine debt, broadly syndicated loans and other credit strategies. Crescent Capital BDC was launched as an exchange-listed vehicle in 2019 on Nasdaq under the ticker CCAP, and it strengthened its footprint through the acquisition of Alcentra Capital Corporation in 2020. Its principal executive offices are in Los Angeles, California, United States, at 11100 Santa Monica Blvd., Suite 2000. The company’s common stock trades on Nasdaq, while certain debt securities are listed on the NYSE, reflecting a capital structure that combines equity-market access with public debt funding.
Read moreShow less
Operationally, Crescent BDC provides financing solutions to middle-market companies, typically in situations involving growth capital, acquisitions, refinancing, recapitalizations or other balance-sheet needs. Its competitive positioning is built around access to Crescent’s sourcing network, a disciplined underwriting approach, and a management team with long experience in sponsored and non-sponsored credit. In a highly competitive market that includes other BDCs, private credit funds, commercial banks, investment banks and specialty finance lenders, success depends on origination depth, credit selection, portfolio monitoring and the ability to structure flexible solutions for borrowers that may not have full access to traditional bank lending.
Geographically, the economic exposure is mainly U.S.-centric, even though the broader Crescent platform also operates across Europe and other credit markets through its wider asset-management franchise. Recent notable developments include the company’s 2025 earnings updates and its reported net asset value of $19.10 per share at December 31, 2025, as well as the declaration of a first-quarter 2026 cash dividend. More broadly, recent Crescent corporate announcements point to continued expansion in private credit capabilities, which supports the long-term relevance of the listed BDC franchise in the United States public markets.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
